NCT00756041 Safety Study of TAK-128 in Subjects With Diabetic Peripheral Neuropathy Status TERMINATED Phase PHASE2
NCT00756002 Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia Status COMPLETED Phase PHASE3
NCT00755846 Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes. Status COMPLETED Phase PHASE2
NCT00755508 Efficacy and Safety of Ramelteon Combined With Gabapentin in Treating Patients With Insomnia Status COMPLETED Phase PHASE2
NCT00755495 Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia Status COMPLETED Phase PHASE2
NCT00754403 Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00752791 Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin. Status COMPLETED Phase PHASE2
NCT00752609 Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa. Status COMPLETED Phase PHASE2
NCT00746395 Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy Status COMPLETED Phase PHASE4
NCT00745030 Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism Status TERMINATED Phase NA
NCT00744627 Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults. Status COMPLETED Phase PHASE3
NCT00739024 A Study of a Melatonin Receptor Agonist to Prevent Migraine Status TERMINATED Phase PHASE2
NCT00738725 BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population Status COMPLETED Phase N/A
NCT00737347 Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone Status COMPLETED Phase PHASE3
NCT00735709 Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00734071 An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder Status COMPLETED Phase PHASE3
NCT00731120 Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder Status COMPLETED Phase PHASE3
NCT00730691 Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder Status COMPLETED Phase PHASE3
NCT00727857 Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus. Status COMPLETED Phase PHASE3
NCT00724542 Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease. Status UNKNOWN Phase NA